Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of GBP 87.31 billion. The enterprise value is 102.64 billion.
Market Cap | 87.31B |
Enterprise Value | 102.64B |
Important Dates
The last earnings date was Tuesday, August 19, 2025.
Earnings Date | Aug 19, 2025 |
Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Current Share Class | 1.28B |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.52% |
Shares Change (QoQ) | -0.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 25.18 and the forward PE ratio is 16.04.
PE Ratio | 25.18 |
Forward PE | 16.04 |
PS Ratio | 3.43 |
PB Ratio | 2.44 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.36, with an EV/FCF ratio of 26.01.
EV / Earnings | 29.60 |
EV / Sales | 4.05 |
EV / EBITDA | 14.36 |
EV / EBIT | 21.14 |
EV / FCF | 26.01 |
Financial Position
The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.59.
Current Ratio | 2.01 |
Quick Ratio | 1.25 |
Debt / Equity | 0.59 |
Debt / EBITDA | 2.95 |
Debt / FCF | 5.39 |
Interest Coverage | 8.89 |
Financial Efficiency
Return on equity (ROE) is 9.74% and return on invested capital (ROIC) is 5.37%.
Return on Equity (ROE) | 9.74% |
Return on Assets (ROA) | 4.54% |
Return on Invested Capital (ROIC) | 5.37% |
Return on Capital Employed (ROCE) | 8.26% |
Revenue Per Employee | 267,905 |
Profits Per Employee | 36,504 |
Employee Count | 95,000 |
Asset Turnover | 0.38 |
Inventory Turnover | 2.10 |
Taxes
In the past 12 months, Medtronic has paid 722.60 million in taxes.
Income Tax | 722.60M |
Effective Tax Rate | 17.15% |
Stock Price Statistics
The stock price has increased by +4.20% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | +4.20% |
50-Day Moving Average | 90.20 |
200-Day Moving Average | 87.42 |
Relative Strength Index (RSI) | 54.86 |
Average Volume (20 Days) | 7,861 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.83 |
Income Statement
In the last 12 months, Medtronic had revenue of GBP 25.45 billion and earned 3.47 billion in profits. Earnings per share was 2.69.
Revenue | 25.45B |
Gross Profit | 16.64B |
Operating Income | 4.88B |
Pretax Income | 4.21B |
Net Income | 3.47B |
EBITDA | 7.00B |
EBIT | 4.88B |
Earnings Per Share (EPS) | 2.69 |
Balance Sheet
The company has 6.04 billion in cash and 21.29 billion in debt, giving a net cash position of -15.23 billion.
Cash & Cash Equivalents | 6.04B |
Total Debt | 21.29B |
Net Cash | -15.23B |
Net Cash Per Share | n/a |
Equity (Book Value) | 35.82B |
Book Value Per Share | 27.80 |
Working Capital | 8.70B |
Cash Flow
In the last 12 months, operating cash flow was 5.32 billion and capital expenditures -1.37 billion, giving a free cash flow of 3.95 billion.
Operating Cash Flow | 5.32B |
Capital Expenditures | -1.37B |
Free Cash Flow | 3.95B |
FCF Per Share | n/a |
Margins
Gross margin is 65.38%, with operating and profit margins of 19.18% and 13.63%.
Gross Margin | 65.38% |
Operating Margin | 19.18% |
Pretax Margin | 16.55% |
Profit Margin | 13.63% |
EBITDA Margin | 27.49% |
EBIT Margin | 19.18% |
FCF Margin | 15.51% |
Dividends & Yields
This stock pays an annual dividend of 2.14, which amounts to a dividend yield of 2.33%.
Dividend Per Share | 2.14 |
Dividend Yield | 2.33% |
Dividend Growth (YoY) | -2.90% |
Years of Dividend Growth | n/a |
Payout Ratio | 77.27% |
Buyback Yield | 2.52% |
Shareholder Yield | 4.85% |
Earnings Yield | 3.97% |
FCF Yield | 4.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Medtronic has an Altman Z-Score of 2.82 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.82 |
Piotroski F-Score | 5 |